Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 2
2010 4
2011 6
2012 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNAs and prostate cancer.
Pang Y, Young CY, Yuan H. Pang Y, et al. Acta Biochim Biophys Sin (Shanghai). 2010 Jun 15;42(6):363-9. doi: 10.1093/abbs/gmq038. Acta Biochim Biophys Sin (Shanghai). 2010. PMID: 20539944 Free article. Review.
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. Liu C, et al. Nat Med. 2011 Feb;17(2):211-5. doi: 10.1038/nm.2284. Epub 2011 Jan 16. Nat Med. 2011. PMID: 21240262 Free PMC article.
MicroRNAs associated with metastatic prostate cancer.
Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y. Watahiki A, et al. PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21980368 Free PMC article.
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Deng G, Dahiya R. Yamamura S, et al. PLoS One. 2012;7(1):e29722. doi: 10.1371/journal.pone.0029722. Epub 2012 Jan 3. PLoS One. 2012. PMID: 22235332 Free PMC article.
MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer.
Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Dall'Oglio MF, Camara-Lopes LH, Srougi M. Leite KR, et al. J Urol. 2011 Mar;185(3):1118-22. doi: 10.1016/j.juro.2010.10.035. Epub 2011 Jan 21. J Urol. 2011. PMID: 21255804
Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells.
Shi GH, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Zhu Y, Zhu YP, Xiao WJ, Ma CG. Shi GH, et al. Acta Pharmacol Sin. 2010 Jul;31(7):867-73. doi: 10.1038/aps.2010.48. Epub 2010 Jun 28. Acta Pharmacol Sin. 2010. PMID: 20581857 Free PMC article.
Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.
Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP. Wang WL, et al. Mol Cancer. 2011 May 18;10:58. doi: 10.1186/1476-4598-10-58. Mol Cancer. 2011. PMID: 21592394 Free PMC article.
Molecular assays for the detection of microRNAs in prostate cancer.
Siva AC, Nelson LJ, Fleischer CL, Majlessi M, Becker MM, Vessella RL, Reynolds MA. Siva AC, et al. Mol Cancer. 2009 Mar 6;8:17. doi: 10.1186/1476-4598-8-17. Mol Cancer. 2009. PMID: 19267923 Free PMC article.
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.
Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB. Rokhlin OW, et al. Cancer Biol Ther. 2008 Aug;7(8):1288-96. doi: 10.4161/cbt.7.8.6284. Epub 2008 Aug 13. Cancer Biol Ther. 2008. PMID: 18497571
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M. Fujita Y, et al. Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1. Biochem Biophys Res Commun. 2008. PMID: 18834855
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page